Türk Medline
ADR Yönetimi
ADR Yönetimi

SCHWARTZ-JAMPEL SYNDROME TYPE 1: COMPOUND HETEROZYGOSITY OF TWO NOVEL VARIANTS

Fatma Güliz ATMACA, Özlem AKGÜN DOĞAN, Büşra KUTLUBAY, Heves KIRMIZIBEKMEZ

Journal of Clinical Research in Pediatric Endocrinology - 2026;18(1):181-185

University of Health Sciences Türkiye, Ümraniye Training and Research Hospital, Clinic of Pediatric Endocrinology, İstanbul, Türkiye

 

Schwartz-Jampel syndrome (SJS) type 1 (OMIM; #255800), a rare cause of skeletal dysplasia, is characterized by myotonic myopathy, chondrodystrophy, short stature, facial and eye abnormalities. SJS type 1 develops due to variations in the HSPG2 gene which produces the "perlecan" molecule, one of the main proteoglycans of the basement membrane. A 6-year-old girl presented with short stature, a mask face, shrunken lips, narrow palpebral opening due to blepharospasm, stiffness of facial muscles, micrognathia, overlapping teeth, a short neck, and a bell-shaped thorax due to myotonic myopathy. She was diagnosed with SJS type 1 due to compound heterozygosity of two novel variations in the HSPG2 gene. In patients with short stature and an accompanying myotonic myopathy SJS should be considered. Compound heterozygosity may cause typical clinical findings of SJS. In case of suspicion creatinine kinase levels can be measured, and the determination of myotonia may require evaluation with electromyography. Once the diagnosis is made, patients should be carefully monitored in terms of growth, neuromuscular disorders, joints problems and bone health.